In clinical trials and animal models, drugs such as sodium glucose co-transporter-2 inhibitors, thiazolidinediones, and metformin (with sitagliptin, liraglutide, or insulin) showed mostly modest beneficial effects on ameliorating hepatic steatosis but were more effective when combined with weight loss5. This evidence concerns the gene INS and Hepatic steatosis.